Cancer Therapy
Findings from University of California, Division of Cardiothoracic Surgery provide new insights into cancer therapy
Published in Cancer Weekly, May 29th, 2007
New investigation results, "Update on the molecular biology of malignant mesothelioma," are detailed in a study published in Cancer. According to recent research published in the journal Cancer, "Malignant mesothelioma (MM) is a highly aggressive tumor with a very poor prognosis. The disease is largely unresponsive to conventional chemotherapy or radiotherapy, and most patients die within 10-17 months of the first symptoms."
"Novel, more effective therapeutic strategies are needed for this inexorably fatal disease. Improvement in our understanding of the molecular biology of MM has identified promising new candidates for targeted treatments," wrote A.Y....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-29)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Medical Research Scientists Make Ethical Value Judgments in Research - Cancer Gene Therapy
Researchers Find a Peptide That Encourages HIV Infection - Cancer Gene Therapy
Researchers Use "Virtual Iraq" Simulation to Study Post-Traumatic Stress Disorder - Astrocytoma
Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion - Biotech Business
Biotech Hub Announces New Tenant - Bird Flu
Carrington Reports First Quarter 2007 Results - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
